{"title":"血管紧张素转换酶抑制剂或血管紧张素-2受体阻滞剂在COVID-19合并心血管或肺部疾病患者中的作用","authors":"F. Rahimi, A. Talebi Bezmin abadi","doi":"10.32598/RMM.8.3.851.6","DOIUrl":null,"url":null,"abstract":"n January 2020, the World Health Organization (WHO) announced the COVID-19 outbreak, caused by SARS-CoV-2, a publichealth emergency [1]. Following the skyrocketing spread of SARS-CoV-2 into more than 210 countries, diverse clinical strategies have been urgently explored against the COVID-19 pandemic while a magic-bullet antiviral vaccine or treatment is unavailable [2]. Although the clinical features of COVID-19 and the epidemiological characteristics of the pandemic have been described, COVID-19 has seemingly evolved, and its new symptoms and associations are being reported over time [3-7]. Nevertheless, SARS-CoV-2 is extremely contagious and new to the human immune system; thus, everyone is vulnerable.","PeriodicalId":30778,"journal":{"name":"Research in Molecular Medicine","volume":"8 1","pages":"103-106"},"PeriodicalIF":0.0000,"publicationDate":"2020-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Inhibitors of Angiotensin-converting Enzyme or Blockers of Angiotensin-2 Receptor in COVID-19 Patients with Comorbid Cardiovascular or Pulmonary Diseases\",\"authors\":\"F. Rahimi, A. Talebi Bezmin abadi\",\"doi\":\"10.32598/RMM.8.3.851.6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"n January 2020, the World Health Organization (WHO) announced the COVID-19 outbreak, caused by SARS-CoV-2, a publichealth emergency [1]. Following the skyrocketing spread of SARS-CoV-2 into more than 210 countries, diverse clinical strategies have been urgently explored against the COVID-19 pandemic while a magic-bullet antiviral vaccine or treatment is unavailable [2]. Although the clinical features of COVID-19 and the epidemiological characteristics of the pandemic have been described, COVID-19 has seemingly evolved, and its new symptoms and associations are being reported over time [3-7]. Nevertheless, SARS-CoV-2 is extremely contagious and new to the human immune system; thus, everyone is vulnerable.\",\"PeriodicalId\":30778,\"journal\":{\"name\":\"Research in Molecular Medicine\",\"volume\":\"8 1\",\"pages\":\"103-106\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-08-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Research in Molecular Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32598/RMM.8.3.851.6\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Molecular Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32598/RMM.8.3.851.6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Inhibitors of Angiotensin-converting Enzyme or Blockers of Angiotensin-2 Receptor in COVID-19 Patients with Comorbid Cardiovascular or Pulmonary Diseases
n January 2020, the World Health Organization (WHO) announced the COVID-19 outbreak, caused by SARS-CoV-2, a publichealth emergency [1]. Following the skyrocketing spread of SARS-CoV-2 into more than 210 countries, diverse clinical strategies have been urgently explored against the COVID-19 pandemic while a magic-bullet antiviral vaccine or treatment is unavailable [2]. Although the clinical features of COVID-19 and the epidemiological characteristics of the pandemic have been described, COVID-19 has seemingly evolved, and its new symptoms and associations are being reported over time [3-7]. Nevertheless, SARS-CoV-2 is extremely contagious and new to the human immune system; thus, everyone is vulnerable.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
